Month: November 2024

Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial

Staff November 1, 2024

Bagsværd, Denmark, 1 November 2024 – Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE...

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

Staff November 1, 2024

Conference call to be held Monday, November 4, 2024, at 8:30 AM ETNEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) --...

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024

Staff November 1, 2024

BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...

The MUHC Foundation and the Beat 92.5’s Raise Craze raises $95,000 to help strike out breast cancer

Staff November 1, 2024

All funds are supporting breast cancer care at the McGill University Health Centre (MUHC) The MUHC Foundation and the Beat...

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

Staff November 1, 2024

SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a...

Month: November 2024

Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024

The MUHC Foundation and the Beat 92.5’s Raise Craze raises $95,000 to help strike out breast cancer

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

Invitation to Presentation of Cantargia’s Interim Report January – September 2024

iZafe Group Q3 Interim Report, July-September 2024

Javid Javdani Calls for Increased Support for Small Business Owners in California

Blake Nations of Doctor’s Medical Weight Loss Clinic Unveils Revolutionary 3D Body Fat Scanning Service to Drive Patient Results and Clinic Success

Nano Positioning Systems Market to Grow by USD 183.95 Million (2024-2028) as AI Powers Market Evolution, Nanotechnology Applications Boost Revenue – Technavio

The Sister Accord® Foundation Brings Its Leadership Development Tea Party Program to Cleveland

Waters Corporation to Present at the Evercore 2024 HealthCONx Conference

PrimeRx Expands Leadership Team, Naming David Kirkus, Pharm.D., as VP of PrimeRx MARKET

You may have missed